LBA3 Enzalutamide in men with chemotherapy-naive metastatic castration resistant prostate cancer (MCRPC): Primary and European regional results of the phase 3 prevail study

B Tombal, P Iversen, K Miller, T Tammela, Michael Borre, A Bjartell, P Mulders, J Kliment, J Ramon, V Matveev

    OriginalsprogEngelsk
    TidsskriftEuropean Urology Supplements
    Vol/bind13
    Udgave nummer1
    Sider (fra-til)LBA3
    ISSN1569-9056
    StatusUdgivet - 2014

    Citationsformater